comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 14:10:22 Page View：9897

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Winners, losers from Medicare’s list of drugs subject to price talks
Next article： Alkermes shareholders re

explore

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

Australia’s approach to dialysis celebrates life

OSCARDELPOZO/AFPviaGettyImagesIn1972,asCongresspromiseddialysisandrehabilitationforallkidneyfailurep

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

After gene therapy, two congenitally deaf children hear for the first time

AdobeTwocongenitallydeafchildrencanhearforthefirsttimeafterbeingtreatedwithgenetherapy,accordingtoda